Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing

Brain

Volumn 133, Issue 8, 2010, Pages 2225-2231

  Dolan, David ^a   Troncoso, Juan ^b   Resnick, Susan M ^c   Crain, Barbara J ^b   Zonderman, Alan B ^c   O'Brien, Richard J ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Ageing; Alzheimer's disease; Natural history; Neurodegenerative mechanisms; Pathology

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; COGNITION; COHORT ANALYSIS; DEMENTIA; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENILE PLAQUE; AGE; AMYLOID PLAQUE; BRAIN; INTRACRANIAL ARTERIOSCLEROSIS; PATHOLOGY; PREVALENCE; RISK; SEVERITY OF ILLNESS INDEX; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BALTIMORE; BRAIN; DEMENTIA; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LONGITUDINAL STUDIES; MALE; NEUROFIBRILLARY TANGLES; PREVALENCE; PROSPECTIVE STUDIES; RISK; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX; PLAQUE, AMYLOID;

EID: 77957030844     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq141     Document Type: Article

References (24)

1. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; 66: 1837-1844
2. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259
3. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25: 7709-7717
4. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-1208
5. Clark C, Trojanowski J. Neurodegenerative dementias, New York, NY: McGraw-Hill, 1999.
6. Driscoll I, Resnick SM, Troncoso JC, An Y, O'Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol 2006; 60: 688-695
7. Gamaldo A, Moghekar A, Kilada S, Resnick SM, Zonderman AB, O'Brien R. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006; 67: 1363-1369
8. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 2008; 65: 1211-1217
9. Jellinger KA. Clinicopathological analysis of dementia disorders in the elderly. J Alzheim Dis 2006; 9: 61-70.
10. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 54: 2072-2077
11. Kern A, Behl C. The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochim Biophys Acta 2009; 1790: 1124-1132
12. Lobo A, Launer LJ, Fratiglioni, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborate study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2008; 54(Suppl 5): S4-9.
13. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872
14. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803-1809
15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486
16. Mohajeri MH, Leuba G. Prevention of age-associated dementia. Brain Res Bull 2009; 80: 315-325
17. Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid b-peptide in the brain and cognitive decline. JAMA 2000; 283: 1571-1577
18. National Center for Education Statistics; Digest of Educational Statistics (2008) http://nces.ed.gov/programs/digest/d08/ (Advance Access published March 2010).
19. Prince M, Jackson J. Alzheimer's Disease International. World Alzheimer Report. 2009. http://www.alz.co.uk/research/worldreport/ (Advance Access published March 2010).
20. Reitz C, Brickman AM, Brown TR, Manly J, DeCarli C, Small SA, et al. Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol 2009; 66: 1385-1392
21. Roe CM, Xiong C, Miller JP, Morris JC. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 2007; 68: 223-228
22. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. New Engl J Med 2009; 360: 2302-2309
23. Selkoe DJ. Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295-18298
24. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; 64: 168-176